Tevogen Clears Both Nasdaq Continued-Listing Compliance Matters
The company said Nasdaq confirmed it met the $50 million listed-securities value requirement, closing its two disclosed compliance matters.
Makkler Newsroom · Oct 1, 12:03 AM · 1 min read
